Advertisement

The Scientist

» drug development and ecology

Most Recent

image: Company Size Won’t Predict Success

Company Size Won’t Predict Success

By | October 23, 2013

New analysis finds that the size of a company is not tied to getting a drug to market.

0 Comments

image: A New Antibiotic?

A New Antibiotic?

By | October 16, 2013

Scientists show that peptide-conjugated phosphorodiamidate morpholino oligomers can effectively silence essential bacterial genes.

2 Comments

image: Centipede Venom Tops Morphine

Centipede Venom Tops Morphine

By | October 1, 2013

The substance targets the same ion channel that's mutated in people who don't feel pain.

0 Comments

image: Speaking of Science

Speaking of Science

By | October 1, 2013

October 2013's selection of notable quotes

0 Comments

image: Influential Ecologist Dies

Influential Ecologist Dies

By | September 24, 2013

Ruth Patrick, who pioneered freshwater pollution monitoring, has passed away at age 105.

1 Comment

image: Opinion: Reasons for the R&D Crisis

Opinion: Reasons for the R&D Crisis

By | September 23, 2013

Response to an opinion in The Scientist charting current pitfalls in translational research

2 Comments

image: Opinion: Sexual Dysfunction Matters

Opinion: Sexual Dysfunction Matters

By | August 19, 2013

Desire and arousal disorders require the biopharmaceutical industry’s attention.

7 Comments

image: Dolphins by Name

Dolphins by Name

By | July 23, 2013

Bottlenose dolphins can recognize and respond to their own “signature whistles,” strengthening the evidence that these whistles function like names.

2 Comments

image: Week in Review, July 15–19

Week in Review, July 15–19

By | July 19, 2013

Bias in preclinical research; medical marijuana for kids; a swath of microbial genomes; plastic ocean habitats; rethinking scientific evaluation

0 Comments

image: Cancer Gene Data Released

Cancer Gene Data Released

By | July 18, 2013

NCI has made public the largest-ever database of cancer-specific gene variations, paving the way for the development of new drugs and therapies.

0 Comments

Advertisement
Lonza Group
Lonza Group

Popular Now

  1. The Zombie Literature
    Features The Zombie Literature

    Retractions are on the rise. But reams of flawed research papers persist in the scientific literature. Is it time to change the way papers are published?

  2. First Data from Anti-Aging Gene Therapy
  3. Locating Language within the Brain
  4. The Two Faces of Fish Oil
    Notebook The Two Faces of Fish Oil

    The discovery of a tumor-protecting role for a fatty acid found in fish oil has sparked debate about the product’s safety.

Advertisement
Diagenode
Diagenode
Advertisement
LabX
LabX
RayBioTech